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Our previous study showed that Schwann cells (SCs) promote survival, proliferation and
migration of co-transplanted oligodendrocyte progenitor cells (OPCs) and neurological
recovery in rats with spinal cord injury (SCI). A subsequent in vitro study confirmed that
SCs modulated OPC proliferation and migration by secreting platelet-derived growth
factor (PDGF)-AA and fibroblast growth factor-2 (FGF)-2. We also found that PDGF-AA
stimulated OPC proliferation and their differentiation into oligodendrocytes (OLs) at later
stages. We therefore speculated that PDGF-AA administration can exert the same
effect as SC co-transplantation in SCI repair. To test this hypothesis, in this study we
investigated the effect of transplanting PDGF-AA-overexpressing OPCs in a rat model
of SCI. We found that PDGF-AA overexpression in OPCs promoted their survival,
proliferation, and migration and differentiation into OLs in vivo. OPCs overexpressing
PDGF-AA were also associated with increased myelination and tissue repair after SCI,
leading to the recovery of neurological function. These results indicate that PDGF-AA-
overexpressing OPCs may be an effective treatment for SCI.
Keywords: platelet-derived growth factor-AA, oligodendrocyte progenitor cells, transplantation, spinal cord injury,
functional recovery
INTRODUCTION
Spinal cord injury (SCI) leads to cell loss and the destruction of descending motor and ascending
sensory tracts, resulting in permanent neurological deficits with limited prospects for spontaneous
recovery (Quencer and Bunge, 1996). A number of SCI treatment strategies to promote endogenous
repair and replace lost cells have been investigated (Thuret et al., 2006; Mothe and Tator, 2012).
Oligodendrocytes (OLs) are myelin-forming cells in the central nervous system (Bunge, 1968); their
loss following SCI leads to demyelination of surviving axons (Crowe et al., 1997; Rabchevsky and
Smith, 2001; Warden et al., 2001; Beattie et al., 2002), suggesting these cells or their precursors
(OL progenitor cells, OPCs) as candidates for cell-based therapy. However, the poor survival of
transplanted OLs and OPCs and inhibition of axonal regeneration are two limitations to their
application (Lü et al., 2010).
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Schwann cells (SCs) are peripheral nervous system-derived
myelin-forming cells that produce growth factors and cell
adhesion molecules (Acheson et al., 1991; Chiu et al., 1991;
Oudega and Xu, 2006). Our previous study showed that
co-transplantation of SCs and OPCs promoted the survival,
proliferation and migration of transplanted OPCs in vivo and
improved neurological recovery following SCI (Hu et al., 2013).
A subsequent in vitro study confirmed that SCs modulated
the proliferation and migration of OPCs by secreting platelet-
derived growth factor (PDGF)-AA and fibroblast growth
factor-2 (FGF)-2 (Chen et al., 2015); moreover, we showed
that PDGF-AA stimulated the proliferation of OPCs and their
differentiation into OLs at later stages (Hu et al., 2008). We
therefore speculated that PDGF-AA administration would have
similar effects as SCs in OPC transplantation for SCI repair. The
present study tested this hypothesis by examining the effect of
transplanted PDGF-AA-overexpressing OPCs on tissue repair
and recovery of neurological function in a rat model of SCI.
MATERIALS AND METHODS
Animals
A total of 145 adult female Sprague-Dawley rats were used in
this study. Of these, 140 8-week-old rats (weighing 220–250 g)
were subjected to contusive SCI and five pregnant rats were
used for OPC isolation and culture. All animal protocols were in
accordance with the Guide for the Care and Use of Laboratory
Animals and the Guidelines and Policies for Rodent Survival
Surgery approved by the Animal Care and Ethics Committees of
Bengbu Medical College.
Embryonic OPC Isolation and Culture
OPCs were isolated from the spinal cords of rat embryos
according to a previously published protocol (Ma et al., 2009;
Hu et al., 2013), with some modifications. Briefly, OPCs were
immunopanned from spinal cords on embryonic day 14 using
a monoclonal anti-A2B5 IgM antibody (1:1; gift from Dr. Scott
R. Whittemore, University of Louisville, KY, USA) and plated
in poly-D-lysine/fibronectin-coated 10 × 12-cm culture dishes
with Dulbecco’s Modified Eagle’s Medium (DMEM)/Ham’s
F12 (D/F12; Invitrogen, Carlsbad, CA, USA), 1× N2, 1×
B27 supplement (Invitrogen), FGF-2 (20 ng/ml) and PDGF-AA
(10 ng/ml). The medium was replaced every other day. After
5–7 days, cells were passaged and OPC purity was evaluated;
the cultures were considered highly pure when >95% of cells
expressed A2B5. Passage 2 cells were used for experiments.
Preparation of Lentiviral Vectors
Expressing PDGF-AA and Enhanced Green
Fluorescent Protein (EGFP)
The lentiviral vectors pLenti6.3-enhanced green fluorescent
protein (EGFP) and pLenti6.3- PDGF-AA-EGFP encoding rat
EGFP and PDGF-AA cDNA, respectively, were generated
by cloning into the pLenti6.3/v5 DEST backbone vector
(Invitrogen). High-titer virus was obtained from human
embryonic 293T cells seeded at 6 × 106/10-cm plate in DMEM
and cultured for 16 h. pLenti6.3-EGFP or pLenti6.3- PDGF-
AA-EGFP along with the packaging plasmids pLP1, pLP2
and pLP/VSVG (Invitrogen) were co-transfected into 293T
cells using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. After 48 h, lentivirus was collected
and concentrated from the medium by ultracentrifugation as
described in our previous report (Hu et al., 2012). For lentiviral
vector transduction, OPCs were cultured in growth medium for
24 h, and then exposed to pLenti6.3-EGFP or pLenti6.3- PDGF-
AA-EGFP with a multiplicity of infection of 15; 24 h later, the
medium was replaced with fresh medium and after another 24 h,
transduction efficiency was estimated by EGFP expression under
an epifluorescence microscope. After 5 days of culture, cells were
passaged and fresh medium containing blasticidin (5 µg/ml) was
added for selection of stably transduced cells. Lentivirus-infected
OPCs were identified under proliferation and differentiation
conditions by immunocytochemistry. OPCs transduced with
pLenti6.3-EGFP or pLenti6.3- PDGF-AA-EGFP lentiviral vector
are henceforth referred to as GFP-OPCs and PDGF-AA-OPCs,
respectively.
PDGF-AA-OPC Transplantation into Rats
Rats were subjected to contusive SCI using the weight-drop
method (Gruner, 1992; Hu et al., 2013). Briefly, dorsal
laminectomy at the T10 level was carried out on anesthetized
adult female rats, and the dorsal surface of the spinal cord was
subjected to a weight-drop impact of 10 g from a height of
12.5 mm. After SCI, muscles and skin were closed in layers,
and rats were placed in a temperature- and humidity-controlled
chamber. Rats received an analgesic agent buprenorphine
(0.3 mg/kg) twice a day for 3 days to alleviate pain. Manual
bladder emptying was performed three times daily until reflex
bladder emptying was established. To prevent infections, animals
were daily provided with chloramphenicol (50–75 mg/kg) via
drinking water. Cell transplantation was performed on day
8 post-SCI. A total of 140 rats were randomly assigned to one of
three groups: (1) control (OPC medium; n = 40); (2) GFP-OPC
(2 × 105; n = 50); and (3) PDGF-AA-OPC (2 × 105; n = 50).
Animals were re-anesthetized and the laminectomy site was
re-exposed. A total of five injections were made into the spinal
cord: one at the lesion center (2 µl of cell suspension at a
concentration of 105 cells/µl), two at 2 mm rostral to the center
on either side, and two at 2 mm caudal to the center on either
side at a depth of 1.2 and 0.6 mm laterally from the midline
(0.5 µl/injection/side). Animals received daily subcutaneous
injections of cyclosporine A (10 mg/kg; Sigma, St. Louis, MO,
USA) starting 3 days prior to the transplantation until week 7
after transplantation, when the rats were sacrificed.
Behavioral Assessment
Open-field locomotor testing was carried out by two trained
investigators using the 21-point Basso, Bresnahan and Beattie
(BBB) locomotor scale (Basso et al., 1995) once a week
post-injury to assess hindlimb locomotor recovery including
joint movement, stepping ability, coordination and trunk
stability. Animals with a minimum BBB score of 12 at 6 weeks
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after cell transplantation were further analyzed and subjected to
grid-walk analyses as described in our previous report (Hu et al.,
2013).
Tissue Preparation
At predetermined time points (1-, 2-, 4- and 7-week post-
transplantation), rats were anesthetized with 60 mg/kg
pentobarbital and transcardially perfused with 4%
paraformaldehyde (PFA) in 0.01 M phosphate-buffered saline
(PBS, pH 7.4). Spinal cord segments containing grafts were
removed, post-fixed in the same fixative overnight at 4◦C, and
cryoprotected in 30% sucrose (Sigma) buffer for 5–7 days. A
2 cm-length of the spinal cord centered at the injection or injury
site was dissected and embedded in HistoPrep (Fisher Scientific,
Pittsburgh, PA, USA) on dry ice. After that the spinal cords
were blocked, serial 20-µm-thick sections through the entire
injury site were cut on a cryostat. At 1-, 2- and 4-week post-
transplantation, all spinal cords from each group (n = 10/group)
were cut as transverse sections; at 7 week post-transplantation,
the spinal cords of 10 animals in each group were cut as
transverse sections, five animals were cut as longitudinal
sections and five animals were used for immunoelectron
microscopy assay in cell-grafted groups, respectively. Sections
were mounted on gelatin-coated slides (Fisher Scientific) and
stored at−70◦C.
Histological Analysis
Two sets of transverse sections (each set containing serial
sections spaced 500 µm apart) from rat spinal cord at 7 weeks
post-SCI were stained with Luxol Fast Blue (LFB; Sigma) for
white matter sparing analysis (n = 10/group) and cresyl violet-
eosin (Sigma) for lesion volume assessment (n = 10/group), as
previously described (Hu et al., 2013). White matter sparing
was defined as tissue exhibiting normal myelin appearance and
density; the lesion center was defined as the section containing
the least amount of spared white matter. The areas of whole
transverse sections and myelinated white matter at the lesion
center were outlined and quantified in LFB-stained sections, and
are expressed as a percentage of the total stained area. After cresyl
violet-eosin staining, total and cross-sectional areas of the spinal
cord and lesion boundary were measured using the Neurolucida
System (MicroBrightField, Colchester, VT, USA) connected to a
BX60 microscope (Olympus, Tokyo, Japan). The total volume of
the lesion area (including areas of cavitation and degeneration)
was calculated as the sum of the individual sub-volumes, which
were determined by multiplying the cross-sectional area by the
distance between sections (500 µm). The percent total volume
of the injured area was calculated by dividing the total volume
of the lesion area by that of the corresponding length of spinal
cord.
Immunohistochemistry
Frozen sections collected on slides were air-dried at room
temperature for 10 min and washed with PBS for 10 min, then
blocked with Tris-buffered saline containing 10% donkey serum
and 0.3% Triton X-100 for 1 h at room temperature. Primary
antibodies in the same blocking solution were applied overnight
at 4◦C. Mouse anti-activated caspase-3 antibody (1:1000; Sigma)
was used to detect cell apoptosis; mouse anti-adenomatous
polyposis coli (CC1, 1:100; Calbiochem, La Jolla, CA, USA),
mouse anti-glial fibrillary acidic protein (GFAP, 1:200; Sigma),
and mouse anti-neurofilament-H (SMI-31, 1:1000; Chemicon,
Billerica, MA, USA) antibodies were used to detect OLs,
astrocytes and axons, respectively. The slides were washed three
times in PBS and incubated with fluorescein isothiocyanate-
or rhodamine-conjugated goat anti-mouse IgG (all at 1:200;
Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at
37◦C. Slides were washed three times with PBS andmounted with
Gel/Mount containing Hoechst 33342 to counterstain nuclei.
Images were acquired with a BX60 fluorescence microscope or
Zeiss 510 laser confocal microscope (Oberkochen, Germany).
Control samples were prepared by omitting the primary
antibody.
Bromodeoxyuridine (BrdU) Incorporation
Assay
To assess OPC proliferation after transplantation, 3 days before
the end of the 1-, 2- and 4-week post-transplantation time
points, randomly selected rats (n = 10/group) were given
10 intraperitoneal injections of bromodeoxyuridine (BrdU;
50 mg/kg/injection; three times daily for 3 days and one injection
on the last day) and were sacrificed 2 h after the last injection.
The animals were perfused, their spinal cords were dissected,
and the tissue was sectioned. One set of serial sections was
randomly selected for the BrdU incorporation assay. Fixed
sections were treated with 1 N HCl for 40 min at 37◦C to
denature the DNA, and a rabbit anti-BrdU antibody (1:100;
Sigma) was applied overnight at 4◦C, followed by rhodamine-
conjugated donkey anti-rabbit IgG (1:200; Sigma) as a secondary
antibody at room temperature for 2 h. BrdU+ cells were imaged
under a BX60 microscope and at least five randomly selected
fields in each section with a total of more than 500 GFP+ cells
were counted. The percentage of BrdU+ GFP+ cells of the total
number of GFP+ cells was determined.
In Vivo Cell Migration Analysis
To analyze the migration ability of grafted cells, we checked all
the longitude sections of all animals with cell transplantation
under Olympus BX60 microscope. We measured the longest
distal distance of the GFP+ cells from the injection sites which
were 2 mm caudal or rostral to the epicenter and then calculated
the average maximum migration distance of each group (n = 5).
Immunoelectron Microscopy
Rats were transcardially perfused with 4% PFA and 0.15%
glutaraldehyde in phosphate buffer (PB). Spinal cords were
postfixed in 4% PFA in 0.1 M PB at 4◦C, then embedded
in 3% agarose A (biotechnology grade; Rose Scientific,
Edmonton, AB, Canada) for vibratome sectioning. Free-floating
sections (100 µm) of the spinal cord were processed for
immunoperoxidase staining by washing three times in PBS and
preincubating in 0.1% H2O2 in PBS for 15 min to quench the
endogenous peroxidase activity. The sections were blocked in 5%
milk, 1% bovine serum albumin, and 0.05% Triton X-100 in PBS
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FIGURE 1 | Transplantation of platelet-derived growth factor
(PDGF)-AA-overexpressing oligodendrocyte progenitor cells (OPCs)
improves locomotor recovery after spinal cord injury (SCI). (A) Rats that
received PDGF-AA-overexpressing OPC transplantation showed greater
improvement in locomotor Basso, Bresnahan and Beattie (BBB) score at
3 weeks as compared to controls (n = 15). (B) The PDGF-AA-overexpressing
OPC transplantation group had fewer footfall errors in the grid-walk analysis
than control animals 6 weeks post-transplantation. Data represent mean ± SD
(n = 15). ∗P < 0.05, ∗∗P < 0.01.
for 3 h at room temperature and incubated in rabbit anti GFP
antibody (1:100; Chemicon) overnight at 4◦C. After three washes
in PBS, sections were incubated in horseradish peroxidase-
conjugated anti-rabbit secondary antibody (1:200) overnight at
4◦C. After washing in PBS, the sections were postfixed in 0.1%
glutaraldehyde for 10 min at room temperature and washed
three times in 0.1 M PB. The slides were incubated in 0.04%
diaminobenzidine (DAB) for 30 min, followed by a second
incubation in 0.04% DAB with 0.005% H2O2 for 15 min. The
sections were washed in PB for 15 min, treated with 1% osmium
FIGURE 2 | Tissue sparing in the spinal cord following SCI.
(A–C) Representative images of sections stained with cresyl violet-eosin
showing the extent of tissue sparing at the lesion center 7 weeks
post-transplantation. (D) Quantitative analysis of relative lesion volume
(n = 10). ∗P < 0.05. Scale bar: 200 µm.
tetroxide in 0.1 M PB overnight, dehydrated in a graded series
of ethanol solutions, and embedded in Araldite 502/Embed-
812 medium (Electron Microscopy Sciences, Hatfield, PA, USA).
Thin sections were cut on an ultramicrotome, counterstained
with uranyl and lead citrate, and examined by transmission
electron microscopy (Hitachi 7000; Hitachi, Tokyo, Japan).
A negative control was prepared by omitting the anti-GFP
antibody.
Statistical Analysis
Data are presented as mean ± standard deviation. One-way
analysis of variance (ANOVA) with Tukey’s Honestly Significant
FIGURE 3 | Survival of OPCs in the injured spinal cord after
transplantation, as determined by activated caspase-3 staining.
(A–F) Representative photomicrographs showing caspase-3+ cells (red)
co-localized with green fluorescent protein (GFP+) OPCs (green) in the spinal
cord of rats that received transplantation of OPCs with or without PDGF-AA
overexpression at 1, 2, or 4 weeks. (G) Quantitative analysis of activated
caspase-3+ cells. There were fewer caspase-3+ GFP+ cells in the
PDGF-AA-overexpressing OPC transplantation group than in the OPC
transplantation groups. Data represent mean ± SD (n = 10). ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001. Scale bar = 25 µm.
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 March 2017 | Volume 11 | Article 79
Yao et al. PDGF-AA-OPCs Promotes Recovery of SCI Rat
Difference or Fisher’s Least Significant Difference post hoc test
was used to evaluate mean differences. BBB score was analyzed
using repeated measure ANOVA, followed by Tukey’s pairwise
comparison at each time point. Other data were analyzed
using non-parametric Kruskal-Wallis ANOVA, followed by
individual Mann-Whitney U tests. A P value <0.05 was
considered statistically significant. Data were analyzed using
SPSS v.14.0 software (SPSS Inc., Chicago, IL, USA).
RESULTS
Transplantation of
PDGF-AA-Overexpressing OPCs Promotes
Functional Recovery after SCI
One day after SCI, all injured rats were paraplegic with no
observable hindlimb movement (BBB = 0, data not shown).
FIGURE 4 | Proliferation of transplanted OPCs in the injured spinal
cord, as determined by bromodeoxyuridine (BrdU) incorporation.
(A–F) Representative photomicrographs showing BrdU+ cells (red)
co-localized with GFP+ OPCs (green) in the spinal cord of rats transplanted
with OPCs with or without PDGF-AA overexpression at 1, 2 and 4 weeks.
(G) Quantitative analysis of OPC proliferation. The number of BrdU+ OPCs
was higher in rats that received transplantation of OPCs overexpressing
PDGF-AA as compared to those that did not express PDGF-AA. Data
represent mean ± SD (n = 10). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Scale
bar = 25 µm.
We assessed the effect of transplanted PDGF-AA-overexpressing
OPCs on functional recovery following SCI with the BBB
test and grid-walking analyses. One week after injury (1 day
before transplantation), the mean BBB score was 8.80 ± 0.51.
In the first 3 weeks after transplantation, there was no
difference among groups in terms of BBB score (Figure 1A).
However, with continued recovery, rats transplanted with
PDGF-AA-OPCs showed a significant improvement in BBB
score as compared to the OPC only or control groups
at 4–6 weeks post-transplantation (P < 0.05, n = 15;
Figure 1A).
Rats were evaluated with the gridwalk test 6 weeks
after transplantation. OPC transplantation alone did not
improve grid walking performance as compared to the control
group (Figure 1B). However, PDGF-AA-OPC transplantation
decreased the number of footfall errors as compared to the OPC
only or control groups (P < 0.05, n = 15; Figure 1B).
Transplantation of
PDGF-AA-Overexpressing OPCs Increases
Tissue Sparing in Injured Spinal Cord
We examined the gross morphology of the injured spinal
cord 7 weeks post-transplantation to determine whether
transplantation of PDGF-AA-overexpressing OPCs can increase
tissue sparing. We found that lesion volume was markedly
decreased upon transplantation of PDGF-AA-overexpressing
OPCs relative to control animals (P < 0.05, n = 10;
Figures 2A–D).
FIGURE 5 | Migration of transplanted OPCs in the spinal cord after
transplantation. (A–D) Representative longitudinal sections showing the
migration of transplanted OPCs over longer distances from the injury center (∗)
when overexpressing PDGF-AA as compared to those without PDGF-AA
overexpression at 7 weeks. Data represent mean ± SD (n = 5). ∗∗∗P < 0.001.
Scale bar = 500 µm.
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FIGURE 6 | Differentiation of transplanted OPCs in the injured spinal cord. (A–K) Representative images showing differentiation of transplanted GFP+ OPCs
into CC1+ oligodendrocytes (OLs) in the spinal cord 7 weeks post-transplantation in the non-PDGF-AA-overexpressing OPC transplantation group (A–C) and
PDGF-AA-overexpressing OPC transplantation group (D–F). (G–L) Representative images showing differentiation of transplanted GFP+ OPCs into astrocytes in the
spinal cord 7 weeks post-transplantation in the non-PDGF-AA-overexpressing OPC transplantation group (G–I) and PDGF-AA-overexpressing OPC transplantation
group (J,K). (M,N) Quantitative analysis of CC1+ OLs (G) and GFAP+ astrocytes. Significant differences in the percentage of CC1+ OLs (M) and GFAP+ astrocytes
(N) were observed between the two transplantation groups. Data represent mean ± SD (n = 10). Scale bar = 25 µm. ∗P < 0.05.
PDGF-AA Overexpression Promotes the
Survival of Transplanted OPCs in Injured
Spinal Cord
Detection of activated caspase-3 at 1, 2 and 4 weeks
post-transplantation revealed that PDGF-AA overexpression
promoted the survival of transplanted OPCs in the injured
spinal cord as compared to the OPC group (P < 0.05;
Figures 3A–G). There were fewer caspase-3+ GFP+ cells
among total GFP+ cells in the PDGF-AA-overexpressing OPC
transplantation group as compared to the OPC group at 1 week
(12.63%± 3.20% vs. 32.35%± 4.13%, P< 0.001, n = 10), 2 weeks
(9.78% ± 2.45% vs. 23.20% ± 3.54%, P < 0.01, n = 10), and
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4 weeks (8.13% ± 2.15% vs. 14.52% ± 2.87%, P < 0.05, n = 10;
Figure 3G).
Overexpression of PDGF-AA Promotes
Proliferation of Transplanted OPCs in
Injured Spinal Cord
The BrdU incorporation assay was used to assess the proliferation
of transplanted OPCs. There were more BrdU+ GFP+ cells
among total GFP+ cells in the PDGF-AA-overexpressing OPC
transplantation group as compared to the OPC group at 1 week
(20.37%± 3.85% vs. 5.20%± 1.34%, P < 0.001, n = 10), 2 weeks
(15.25% ± 2.82% vs. 3.50% ± 1.24%, P < 0.01, n = 10), and
4 weeks (4.12% ± 1.62% vs. 2.70% ± 0.90%, P < 0.05, n = 10;
Figure 4).
Overexpression of PDGF-AA Promotes
Migration of Transplanted OPCs in Injured
Spinal Cord
The migration of OPCs in the injured spinal cord was
examined 7 weeks after transplantation (Figures 5A–D).
Numerous GFP+ OPCs had migrated away from the injury
center in rats that received transplantation of PDGF-AA-
overexpressing OPCs (Figure 5B). These results indicate
that PDGF-AA overexpression stimulated migration of
transplanted OPCs as compared to those that did not
express PDGF-AA (Figures 5A–C). Moreover, the number
of transplanted GFP+ OPCs was higher in the PDGF-AA-
overexpressing OPC transplantation as compared to the OPC
group (Figures 5A,B,D).
Overexpression of PDGF-AA Stimulates
Differentiation of Transplanted OPCs into
OLs
To assess the effect of PDGF-AA overexpression on the
differentiation of transplanted OPCs, we compared the numbers
of transplanted GFP-OPCs and PDGF-AA-overexpressing OPCs
that differentiated into CC1+OLs and GFAP+ astrocytes 7 weeks
after transplantation (Figure 6). The percentage of CC1+ OLs
was higher in the PDGF-AA-OPC group (46.20% ± 5.50%,
P < 0.05, n = 10), than in the OPC group (36.81% ± 4.20%,
P < 0.05, n = 10; Figures 6A–F,M). Conversely, the percentage
of GFAP+ astrocytes was lower in the PDGF-AA-overexpressing
OPCs group (48.30% ± 4.92%, P < 0.05, n = 10) as compared
to the OPC group (57.81% ± 6.50%, P < 0.05, n = 10;
Figures 6G–L,N). These findings indicate that PDGF-AA
overexpression induces the differentiation of transplanted OPCs
into OLs.
Transplantation of
PDGF-AA-Overexpressing OPCs Increases
Myelination in Injured Spinal Cord
To investigate whether transplantation of PDGF-AA-
overexpressing OPCs better preserve existing myelin and/or
promote remyelination, LFB staining was performed to assess
the extent of residual or newly formed myelin at the injury center
FIGURE 7 | Detection of myelination and remyelination by luxol fast
blue (LFB) staining and immunoelectron microscopy in rats with SCI
7 weeks after OPC transplantation. (A–C) Representative images of
stained sections showing the extent of myelination at the injury center 7 weeks
after transplantation. (D) Quantitative analysis of myelinated areas (n = 10,
∗P < 0.05). (E,F) Ultrastructural analysis of an OPC-derived mature
oligodendrocyte near newly formed central myelin sheaths (arrows). GFP
immunoreactivity is clearly seen within the myelin sheaths, confirming their
origin from a transplanted OPC. (G) Quantitative analysis of GFP+ myelin
sheaths showed a significant difference between the
non-PDGF-AA-overexpressing OPC transplantation group and the
PDGF-AA-overexpressing OPC transplantation group. ∗∗P < 0.01;
∗∗∗P < 0.001. Scale bar: 200 µm in (A–C).
7 weeks after transplantation. Although transplantation of OPCs
increased the area of LFB staining at the injury center relative to
the control group (P < 0.05, n = 10), the area was greater in rats
transplanted with OPCs overexpressing PDGF-AA as compared
to those that did not expression PDGF-AA (P < 0.01, n = 10;
Figures 7A–D). We further assessed the ability of OLs newly
generated from transplanted OPCs to formmyelin on existing or
regenerated axons by immunoelectron microscopy 7 weeks post-
transplantation. Our results revealed GFP immunoreactivity
in newly formed myelin sheaths generated by OLs derived
Frontiers in Cellular Neuroscience | www.frontiersin.org 7 March 2017 | Volume 11 | Article 79
Yao et al. PDGF-AA-OPCs Promotes Recovery of SCI Rat
from transplanted OPCs (Figures 7E,F). There was a higher
percentage of the GFP+ myelin sheaths in the PDGF-AA-
overexpressing OPC transplantation group as compared to the
OPC transplantation group (Figure 7G).
DISCUSSION
We previously showed that co-transplantation of SCs promoted
the survival, proliferation and migration of transplanted OPCs
and enhanced functional recovery after SCI (Hu et al.,
2013). SCs modulate OPC proliferation and migration via
secretion of PDGF-AA and FGF-2 (Chen et al., 2015). In the
present study, we investigated whether transplantation of OPCs
overexpressing PDGF-AA could improve functional recovery
after SCI. In the first 3 weeks after transplantation, there
was no difference in BBB score among groups. However,
at 4–6 weeks post-transplantation, there was a significant
improvement in the BBB score in rats that received PDGF-
AA-overexpressing OPCs as compared to OPCs that did not
overexpress PDGF-AA. We also found that rats in the PDGF-
AA-overexpressing OPC transplantation group showed greater
improvement in the gridwalk test, another functional measure,
at week 6 as compared to the other groups. These behavioral
findings are consistent with our previous results of OPC/SC
co-transplantation, suggesting that the effect of PDGF-AA
overexpression in OPCs is similar to SC co-transplantation
(Hu et al., 2013) and is a potential alternative strategy for SCI
treatment.
We next evaluated whether transplantation of PDGF-
AA-overexpressing OPCs can promote tissue repair in the
injured spinal cord. We observed a significant reduction in
spinal cord lesion volume in rats that received with PDGF-
AA-overexpressing OPCs as compared to non-PDGF-AA-
overexpressing OPCs or control rats, indicating that PDGF-AA
overexpression in OPCs enhances tissue repair following SCI
and explaining the functional improvement observed in these
animals.
To investigate the mechanism by which PDGF-AA
overexpression promotes functional recovery and tissue
repair following SCI, we examined the growth of transplanted
OPCs overexpressing PDGF-AA. Activated caspase-3 labeling
and BrdU incorporation revealed that PDGF-AA overexpression
protected OPCs from apoptosis and promoted their survival
and proliferation after transplantation. Moreover, these cells
migrated longer distances than non-PDGF-AA-overexpressing
OPCs and showed increased OL differentiation at 7 weeks. These
results suggest that PDGF-AA overexpression in OPCs induces
the differentiation of OPCs into OLs instead of astrocytes at
a later stage after transplantation. This result contradicts our
previous observation that SCs did not affect OL differentiation
of co-transplanted OPCs at the site of injury (Hu et al., 2013),
but is in agreement with our earlier study that PDGF-AA
induced proliferation and possibly differentiation at later stages
of OL development in vitro (Hu et al., 2008). Taken together,
our results suggest that PDGF-AA overexpression promotes
the survival, proliferation and migration of OPCs at an earlier
stage and enhances OL differentiation at a later stage after
transplantation.
Functional recovery following SCI depends on preservation
of existing myelin and remyelination (Keirstead et al., 2005;
Xu and Onifer, 2009). In the present study, there was more
residual myelin at the injury center in rats that received PDGF-
AA-overexpressing OPC transplantation as compared to non-
PDGF-AA-overexpressing OPCs. Immunoelectron microscopy
analysis revealed GFP immunoreactivity in newly formed myelin
sheath produced by transplanted OPC-derived OLs at 7 weeks,
indicating that PDGF-AA overexpression in OPCs preserves
residual myelin and promotes remyelination of demyelinated
axons when transplanted into the injured spinal cord.
As previously mentioned, SCs promote OPC proliferation
and migration through secreting PDGF-AA and FGF-2 (Chen
et al., 2015). In the present study, we only explored the effect
of PDGF-AA-overexpressing OPCs on SCI. Whether FGF-2-
overexpressing OPCs also have a role in SCI repair remains
unknown. Moreover, it must be noted that there is still the
possibility that PDGF-AA which is secreted transplanted PDGF-
AA-overexpressing OPCs could affect endogenous OPCs and
thus promote SCI repair. These questions will be explored in our
future study.
In conclusion, our results demonstrate that PDGF-AA
overexpression in OPCs promoted the survival, proliferation,
migration and OL differentiation of OPCs in vivo, which
increasedmyelination and tissue repair in the injured spinal cord,
leading to the recovery of neurological function. These results
suggest that transplanting PDGF-AA-overexpressing OPCs is a
potentially effective strategy for SCI treatment.
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